1. UnitedHealth (UNH) and Molina Healthcare (MOH) face challenges from rising medical costs and regulatory pressures but may present undervalued investment opportunities; 2. UNH benefits from scale and diversification but is weighed down by DOJ investigations and leadership changes, while MOH has lower exposure to pharmacy inflation risks but struggles with negative cash flow; 3. The author suggests waiting for technical momentum to improve before investing, using covered calls on UNH and monitoring MOH for a potential rebound.